Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

5ZV3

Crystal structure of human anti-tau antibody CBTAU-28.1 in complex with its tau peptide

5ZV3 の概要
エントリーDOI10.2210/pdb5zv3/pdb
分子名称Peptide from Microtubule-associated protein tau, Heavy chain of antibody CBTAU28.1, Light chain (kappa) of antibody CBTAU28.1, ... (4 entities in total)
機能のキーワードantibody, tau protein, peptide antigen, immune system
由来する生物種Homo sapiens
詳細
タンパク質・核酸の鎖数3
化学式量合計50689.00
構造登録者
Zhang, H.,Wilson, I.A. (登録日: 2018-05-09, 公開日: 2018-06-20, 最終更新日: 2024-10-09)
主引用文献Apetri, A.,Crespo, R.,Juraszek, J.,Pascual, G.,Janson, R.,Zhu, X.,Zhang, H.,Keogh, E.,Holland, T.,Wadia, J.,Verveen, H.,Siregar, B.,Mrosek, M.,Taggenbrock, R.,Ameijde, J.,Inganas, H.,van Winsen, M.,Koldijk, M.H.,Zuijdgeest, D.,Borgers, M.,Dockx, K.,Stoop, E.J.M.,Yu, W.,Brinkman-van der Linden, E.C.,Ummenthum, K.,van Kolen, K.,Mercken, M.,Steinbacher, S.,de Marco, D.,Hoozemans, J.J.,Wilson, I.A.,Koudstaal, W.,Goudsmit, J.
A common antigenic motif recognized by naturally occurring human VH5-51/VL4-1 anti-tau antibodies with distinct functionalities.
Acta Neuropathol Commun, 6:43-43, 2018
Cited by
PubMed Abstract: Misfolding and aggregation of tau protein are closely associated with the onset and progression of Alzheimer's Disease (AD). By interrogating IgG memory B cells from asymptomatic donors with tau peptides, we have identified two somatically mutated V5-51/V4-1 antibodies. One of these, CBTAU-27.1, binds to the aggregation motif in the R3 repeat domain and blocks the aggregation of tau into paired helical filaments (PHFs) by sequestering monomeric tau. The other, CBTAU-28.1, binds to the N-terminal insert region and inhibits the spreading of tau seeds and mediates the uptake of tau aggregates into microglia by binding PHFs. Crystal structures revealed that the combination of V5-51 and V4-1 recognizes a common Pro-X-Lys motif driven by germline-encoded hotspot interactions while the specificity and thereby functionality of the antibodies are defined by the CDR3 regions. Affinity improvement led to improvement in functionality, identifying their epitopes as new targets for therapy and prevention of AD.
PubMed: 29855358
DOI: 10.1186/s40478-018-0543-z
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.093 Å)
構造検証レポート
Validation report summary of 5zv3
検証レポート(詳細版)ダウンロードをダウンロード

252456

件を2026-04-22に公開中

PDB statisticsPDBj update infoContact PDBjnumon